Skip to main content

Coverage with evidence development for Medicare beneficiaries: challenges and next steps.

Publication ,  Journal Article
Daniel, GW; Rubens, EK; McClellan, M
Published in: JAMA internal medicine
July 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA internal medicine

DOI

EISSN

2168-6114

ISSN

2168-6106

Publication Date

July 2013

Volume

173

Issue

14

Start / End Page

1281 / 1282

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Organizational Policy
  • Medicare
  • Insurance Coverage
  • Humans
  • Evidence-Based Medicine
  • Decision Making
  • Centers for Medicare and Medicaid Services, U.S.
  • 4203 Health services and systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Daniel, G. W., Rubens, E. K., & McClellan, M. (2013). Coverage with evidence development for Medicare beneficiaries: challenges and next steps. JAMA Internal Medicine, 173(14), 1281–1282. https://doi.org/10.1001/jamainternmed.2013.6793
Daniel, Gregory W., Erin K. Rubens, and Mark McClellan. “Coverage with evidence development for Medicare beneficiaries: challenges and next steps.JAMA Internal Medicine 173, no. 14 (July 2013): 1281–82. https://doi.org/10.1001/jamainternmed.2013.6793.
Daniel GW, Rubens EK, McClellan M. Coverage with evidence development for Medicare beneficiaries: challenges and next steps. JAMA internal medicine. 2013 Jul;173(14):1281–2.
Daniel, Gregory W., et al. “Coverage with evidence development for Medicare beneficiaries: challenges and next steps.JAMA Internal Medicine, vol. 173, no. 14, July 2013, pp. 1281–82. Epmc, doi:10.1001/jamainternmed.2013.6793.
Daniel GW, Rubens EK, McClellan M. Coverage with evidence development for Medicare beneficiaries: challenges and next steps. JAMA internal medicine. 2013 Jul;173(14):1281–1282.

Published In

JAMA internal medicine

DOI

EISSN

2168-6114

ISSN

2168-6106

Publication Date

July 2013

Volume

173

Issue

14

Start / End Page

1281 / 1282

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Organizational Policy
  • Medicare
  • Insurance Coverage
  • Humans
  • Evidence-Based Medicine
  • Decision Making
  • Centers for Medicare and Medicaid Services, U.S.
  • 4203 Health services and systems